Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

hepatocellular carcinoma

  • You have access
    Homochlorcyclizine Dihydrochloride Inhibits Hepatocellular Carcinoma Progression and Cancer Stem Cell Properties
    JIAYI WU, XINZHU FU, SHIYUAN CHANG and WEIJUN SU
    Anticancer Research December 2025, 45 (12) 5465-5475; DOI: https://doi.org/10.21873/anticanres.17882
  • You have access
    Precise Anatomical Resection of the Left Lateral Section Using Extrahepatic Glissonean Approach and Fluorescence Guidance
    NOBUHISA TANIOKA, SATORU SEO, YASUHIRO KAWANISHI, KAZUNE FUJISAWA, MASAYA MUNEKAGE, MAEDA HIROMICHI and HIROYUKI KITAGAWA
    Anticancer Research December 2025, 45 (12) 5689-5695; DOI: https://doi.org/10.21873/anticanres.17902
  • You have access
    Prior Radiotherapy Improves Progression-free Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Tremelimumab–Durvalumab
    AKIFUMI KUWANO, KOSUKE TANAKA, TAIKAN HAMAMOTO, KAZUKI KUROSAKA, HIDEO SUZUKI, MASAYOSHI YADA, YOSHIHIRO OHISHI, TOMONARI SASAKI and KENTA MOTOMURA
    Anticancer Research December 2025, 45 (12) 5697-5708; DOI: https://doi.org/10.21873/anticanres.17903
  • You have access
    Carbon-ion Radiotherapy for Hepatocellular Cancer Arising in Transplanted Liver Tissue
    KAZUHIKO HAYASHI, OSAMU SUZUKI, KOJI ICHISE, HIROFUMI UCHIDA, FUMIKO NAGANO, AZUSA HASEGAWA, SHINICHI SHIMIZU, JIRO FUJIMOTO and KAZUHIKO OGAWA
    Anticancer Research December 2025, 45 (12) 5807-5812; DOI: https://doi.org/10.21873/anticanres.17913
  • You have access
    Cost-effectiveness Analysis of Atezolizumab Plus Bevacizumab Versus Lenvatinib in Intermediate-stage Hepatocellular Carcinoma: A Real-world Retrospective Study
    AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, TAIKAN HAMOMOTO, KAZUKI KUROSAKA, HIDEO SUZUKI and KENTA MOTOMURA
    Anticancer Research October 2025, 45 (10) 4627-4636; DOI: https://doi.org/10.21873/anticanres.17808
  • You have access
    Antitumor Potential of Epigallocatechin Gallate in Overcoming Molecular Therapy Resistance in Hepatocellular Carcinoma
    ATSUO KITAOKA, KYOKO OURA, KOJI FUJITA, KOTA SASAKI, FUMIYUKI SUETSUGU, MAI NAKAHARA, TOMOKO TADOKORO, SHIMA MIMURA, JOJI TANI, ASAHIRO MORISHITA, ERIKA OMAYU, HISAKAZU IWAMA, TSUTOMU MASAKI and HIDEKI KOBARA
    Anticancer Research October 2025, 45 (10) 4211-4229; DOI: https://doi.org/10.21873/anticanres.17773
  • You have access
    The Macrophage Activation Marker Soluble CD163 Predicts the Response to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma
    SOICHI TAKEDA, TADASHI NAMISAKI, ARITOSHI KOIZUMI, HIROAKI TAKAYA, YUKI TSUJI, AKIHIKO SHIBAMOTO, SATOSHI IWAI, TAKASHI INOUE, YUKIHISA FUJINAGA, NORIHISA NISHIMURA, SHINYA SATO, KOH KITAGAWA, KOSUKE KAJI, AKIRA MITORO, KIYOSHI ASADA and HITOSHI YOSHIJI
    Anticancer Research October 2025, 45 (10) 4493-4507; DOI: https://doi.org/10.21873/anticanres.17797
  • You have access
    Impact of Tumor Size on Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiotherapy
    WEI-HSUAN HO, YAN-CI JHUANG, JI-AN LIANG, YING-CHUN LIN and SHANG-WEN CHEN
    Anticancer Research September 2025, 45 (9) 3961-3970; DOI: https://doi.org/10.21873/anticanres.17754
  • You have access
    Standardized Technique for Minimally Invasive Right Posterior Sectionectomy for Hepatocellular Carcinoma: A Propensity Score-matched Study
    HISAMUNE SAKAI, YUICHI GOTO, SHOGO FUKUTOMI, SHOICHIROU ARAI, RYUTA MIDORIKAWA, KAZUAKI HASHIMOTO, DAIKI MIYAZAKI, MASANORI AKASHI, NOBUYA ISHIBASHI, KOJI OKUDA, FUMIHIKO FUJITA and TORU HISAKA
    Anticancer Research August 2025, 45 (8) 3497-3510; DOI: https://doi.org/10.21873/anticanres.17711
  • You have access
    Short- and Long-term Outcomes of Laparoscopic Versus Open Repeat Hepatectomy for Hepatocellular Carcinoma
    SHOGO FUKUTOMI, HISAMUNE SAKAI, YUICHI GOTO, KAZUAKI HASHIMOTO, RYUTA MIDORIKAWA, SHOICHIRO ARAI, MASANORI AKASHI, TARO ISOBE, TAKEHUMI YOSHIDA, NAOKI MORI, NOBUYA ISHIBASHI, FUMIHIKO FUJITA and TORU HISAKA
    Anticancer Research August 2025, 45 (8) 3523-3530; DOI: https://doi.org/10.21873/anticanres.17713

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 29
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire